MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 7.38
-0.30 (-3.91%)
At close: Feb 20, 2026
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €138.87 million as of February 20, 2026. Its market cap has increased by 36.09% in one year.
Market Cap
138.87M
Enterprise Value
138.23M
Revenue
3.92M
Ranking
n/a
PE Ratio
n/a
Stock Price
€7.38
Market Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has increased from 132.73M to 138.87M, an increase of 4.62%. That is a compound annual growth rate of 1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 138.87M | 79.26% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genfit | 392.39M |
| Cellectis | 245.91M |
| Transgene | 221.80M |
| Adocia | 136.76M |
| Innate Pharma | 135.53M |
| ABIONYX Pharma | 118.36M |
| OSE Immunotherapeutics | 96.41M |
| Sensorion | 94.91M |